Novo Nordisk and GoodRx announced a partnership this week to sell products Ozempic and Wegovy at half their normal cost to ...

Novo Nordisk (NYSE: NVO) stock is up 2.2% through 10:30 a.m. ET on Viking's bad news. Where to invest $1,000 right now? Our ...

Home Depot kicked off this week's string of retailer earnings reports. Novo Nordisk provided two major updates on its ...

Novo Nordisk is slashing the price of its blockbuster diabetes drug Ozempic for U.S. patients who self-pay or are uninsured.

Novo Nordisk lowers Ozempic cost to $499 per month for uninsured U.S. patients, expanding access through NovoCare and 70,000 ...

Novo said cash-paying Americans can now buy Ozempic for $499 per month through various channels including its official ...

In a notable financial update, Novo Nordisk A/S (NYSE:NVO) has reported an impressive 18% sales growth for the first half of 2025. However, this optimistic growth comes with a caveat: the company has ...

Novo Nordisk revealed on Monday that US patients can now receive a month’s supply of Ozempic, a highly effective diabetes ...

Novo Nordisk A/S (NYSE:NVO) has recently made headlines with its robust financial performance, reporting an 18% sales growth in the first half of 2025. This impressive figure positions Novo Nordisk as ...

(CNN) - Patients in the United States can now get the popular diabetes and weight loss drug Ozempic for half the price. Novo ...

Novo Nordisk and Eli Lilly (NYSE:LLY) shares edged higher Tuesday following results from Viking Therapeutics’ Phase 2 VENTURE-Oral Dosing trial for its oral obesity treatment.

GoodRx (Nasdaq: GDRX) has teamed up with Novo Nordisk (NOV: N) to make all dose levels of Ozempic (semaglutide) and Wegovy ...